Bone status in patients with epilepsy: relationship to markers of bone remodeling

Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 m...

Full description

Bibliographic Details
Main Authors: Sherifa Ahmed Hamed, Ehab eMansour, Ahmed Hamdy Youssef, Mohammed eAbd ElHameed, Eman eMohamad
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/full
id doaj-af08b30aa3024c5a96e510014ea2cb70
record_format Article
spelling doaj-af08b30aa3024c5a96e510014ea2cb702020-11-24T22:48:05ZengFrontiers Media S.A.Frontiers in Neurology1664-22952014-08-01510.3389/fneur.2014.00142103586Bone status in patients with epilepsy: relationship to markers of bone remodelingSherifa Ahmed Hamed0Ehab eMansour1Ahmed Hamdy Youssef2Mohammed eAbd ElHameed3Eman eMohamad4Assiut University HospitalAssiut University HospitalAssiut University HospitalAssiut University HospitalAssiut University HospitalPatients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 matched healthy controls. Bone mineral content (BMC) and densities (BMD) of the femoral neck and lumbar spine were measured using dual energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor kB ligand (sRANKL), osteoprotegerin (OPG) and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score and T-score at the femoral neck and lumbar spine (all p<0.001). 72% and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D and OPG and higher ALP, sRANKL levels and sRANKL/OPG (all p<0.001). 52% of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p=0.043; p=0.010), duration of treatment with AEDs (p<0.001; p=0.012) and serum levels of 25(OH)D (p<0.042; p=0.010), sRANKLs (p=0.005; p=0.01) and OPG (p<0.006; p<0.01). In linear regression analysis and after adjusting for gender, age, weight, duration and number of AEDs, we observed an association between BMD, 25(OH)D (p=0.04) and sRANKL (p=0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms.http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/fullOsteoprotegerinantiepileptic drugsbone mineral density25OHDreceptor activator of nuclear factor-kappa B ligand
collection DOAJ
language English
format Article
sources DOAJ
author Sherifa Ahmed Hamed
Ehab eMansour
Ahmed Hamdy Youssef
Mohammed eAbd ElHameed
Eman eMohamad
spellingShingle Sherifa Ahmed Hamed
Ehab eMansour
Ahmed Hamdy Youssef
Mohammed eAbd ElHameed
Eman eMohamad
Bone status in patients with epilepsy: relationship to markers of bone remodeling
Frontiers in Neurology
Osteoprotegerin
antiepileptic drugs
bone mineral density
25OHD
receptor activator of nuclear factor-kappa B ligand
author_facet Sherifa Ahmed Hamed
Ehab eMansour
Ahmed Hamdy Youssef
Mohammed eAbd ElHameed
Eman eMohamad
author_sort Sherifa Ahmed Hamed
title Bone status in patients with epilepsy: relationship to markers of bone remodeling
title_short Bone status in patients with epilepsy: relationship to markers of bone remodeling
title_full Bone status in patients with epilepsy: relationship to markers of bone remodeling
title_fullStr Bone status in patients with epilepsy: relationship to markers of bone remodeling
title_full_unstemmed Bone status in patients with epilepsy: relationship to markers of bone remodeling
title_sort bone status in patients with epilepsy: relationship to markers of bone remodeling
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2014-08-01
description Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease, however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90±5.62years; duration of treatment with AEDs: 10.57±3.55years) and 40 matched healthy controls. Bone mineral content (BMC) and densities (BMD) of the femoral neck and lumbar spine were measured using dual energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor kB ligand (sRANKL), osteoprotegerin (OPG) and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score and T-score at the femoral neck and lumbar spine (all p<0.001). 72% and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D and OPG and higher ALP, sRANKL levels and sRANKL/OPG (all p<0.001). 52% of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p=0.043; p=0.010), duration of treatment with AEDs (p<0.001; p=0.012) and serum levels of 25(OH)D (p<0.042; p=0.010), sRANKLs (p=0.005; p=0.01) and OPG (p<0.006; p<0.01). In linear regression analysis and after adjusting for gender, age, weight, duration and number of AEDs, we observed an association between BMD, 25(OH)D (p=0.04) and sRANKL (p=0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms.
topic Osteoprotegerin
antiepileptic drugs
bone mineral density
25OHD
receptor activator of nuclear factor-kappa B ligand
url http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00142/full
work_keys_str_mv AT sherifaahmedhamed bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling
AT ehabemansour bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling
AT ahmedhamdyyoussef bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling
AT mohammedeabdelhameed bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling
AT emanemohamad bonestatusinpatientswithepilepsyrelationshiptomarkersofboneremodeling
_version_ 1725679753189392384